The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ATAI Life Sciences N.V shares valued at $233,830 were purchased by SAHIL KIRPEKAR on Jul 02 ’25. At $2.81 per share, SAHIL KIRPEKAR acquired 83,332 shares.
Also, SAHIL KIRPEKAR purchased 106,093 shares, netting a total of over 294,381 in proceeds.
Before that, SAHIL KIRPEKAR had added 80,000 shares to its account. In a trade valued at $198,408, the Officer bought ATAI Life Sciences N.V shares for $2.48 each.
As published in their initiating research note from Oppenheimer on July 29, 2025, ATAI Life Sciences N.V [ATAI] has been an Outperform and the price target has been revised to $14. Analysts at H.C. Wainwright resumed the stock at ‘”a Buy”‘ outlook in a report released in mid November. As of April 03, 2024, Maxim Group has increased its “Hold” rating to a “Buy” for ATAI. Earlier on November 01, 2022, Loop Capital initiated its rating. Their recommendation was “a Buy” for ATAI stock.
Analyzing ATAI Stock Performance
On last trading session,, ATAI Life Sciences N.V [NASDAQ: ATAI] rose 4.83% to $3.47. The stock’s lowest price that day was $3.3, but it reached a high of $3.55 in the same session. During the last five days, there has been a drop of approximately -10.57%. Over the course of the year, ATAI Life Sciences N.V shares have jumped approximately 118.24%.
Support And Resistance Levels for ATAI Life Sciences N.V (ATAI)
RSI (Relative Strength Index) is 63.60 on the 14-day chart, showing neutral technical sentiment.
Is ATAI Life Sciences N.V subject to short interest?
Stocks of ATAI Life Sciences N.V saw a sharp rise in short interest on 2025-07-15 jumping by 5.21 million shares to 16.18 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 10.96 million shares. A jump of 32.22% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.68 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.68.
Which companies own the most shares of ATAI Life Sciences N.V (ATAI)?
In terms of ATAI Life Sciences N.V share price expectations, FactSet research, analysts set an average price target of 5 in the next 12 months, up nearly 51.06% from the previous closing price of $3.31. Analysts anticipate ATAI Life Sciences N.V stock to reach 5 by 2025, with the lowest price target being 5. In spite of this, 1 analysts ranked ATAI Life Sciences N.V stock as Buy at the end of 2025. On November 30, 2021, Maxim Group assigned a price target of “a Buy” to the stock and initiated coverage with a $25.
